Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cardiotoxicity surveillance and risk of heart failure during HER2 targeted therapy
    Journal Article

    Yu, A. F.; Moskowitz, C. S.; Chuy, K. L.; Yang, J.; Dang, C. T.; Liu, J. E.; Oeffinger, K. C.; Steingart, R. M.
    JACC: CardioOncology (2020)

    Fulltext@MSK | Save
  • Molecular downstaging: A new paradigm for neoadjuvant endocrine therapy
    Editorial

    Ferraro, E.; Fornier, M. N.
    Annals of Translational Medicine (2020)

    Fulltext@MSK | Save
  • A randomized placebo controlled phase II trial evaluating exemestane with or without enzalutamide in patients with hormone receptor-positive breast cancer
    Journal Article

    Krop, I.; Abramson, V.; Colleoni, M.; Traina, T.; Holmes, F.; Garcia-Estevez, L.; Hart, L.; Awada, A.; Zamagni, C.; Morris, P. G.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Phase Ib dose-escalation/expansion trial of ribociclib in combination with everolimus and exemestane in postmenopausal women with HR(+), HER2(-) advanced breast cancer
    Journal Article

    Bardia, A.; Modi, S.; Oliveira, M.; Cortes, J.; Campone, M.; Ma, B.; Dirix, L.; Weise, A.; Hewes, B.; Diaz-Padilla, I.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Combining a novel dual RAF/MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Mehanna, N.; Falik, N.; Rosen, N.; Merghoub, T.; Wolchok, J. D.
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • HER2CLIMB-02: A randomized, double-blind, phase III study of tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer
    Meeting Abstract

    Masuda, N.; Hurvitz, S.; Vahdat, L.; Harbeck, N.; Wolff, A. C.; Tolaney, S. M.; Loi, S.; O'Shaughnessy, J.; Xie, D.; Walker, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • KEYLYNK-009: A phase II/III, open-label, randomized study of pembrolizumab (pembro) + olaparib (ola) vs pembro + chemotherapy after induction with first-line (1L) pembro + chemo in patients (pts) with locally recurrent inoperable or metastatic TNBC
    Meeting Abstract

    Saji, S.; Llombart Cussac, A.; Andre, F.; Robson, M. E.; Harbeck, N.; Schmid, P.; Cescon, D. W.; Ahn, J. S.; Nanda, R.; Fan, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Trastuzumab: Weighing the benefits and the risks
    Editorial

    Blaes, A. H.; Dang, C.
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D
    Journal Article

    Yang, X.; Song, H.; Leslie, G.; Engel, C.; Hahnen, E.; Auber, B.; Horváth, J.; Kast, K.; Niederacher, D.; Turnbull, C.; more...
    JNCI: Journal of the National Cancer Institute (2020)

    Fulltext@MSK | Save
  • TBCRC 048: Phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes
    Journal Article

    Tung, N. M.; Robson, M. E.; Ventz, S.; Santa-Maria, C. A.; Nanda, R.; Marcom, P. K.; Shah, P. D.; Ballinger, T. J.; Yang, E. S.; Vinayak, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save